198 related articles for article (PubMed ID: 23180236)
1. Assessment of fungal viability after long-wave ultraviolet light irradiation combined with riboflavin administration.
Kashiwabuchi RT; Carvalho FR; Khan YA; Hirai F; Campos MS; McDonnell PJ
Graefes Arch Clin Exp Ophthalmol; 2013 Feb; 251(2):521-7. PubMed ID: 23180236
[TBL] [Abstract][Full Text] [Related]
2. Assessment of rose bengal versus riboflavin photodynamic therapy for inhibition of fungal keratitis isolates.
Arboleda A; Miller D; Cabot F; Taneja M; Aguilar MC; Alawa K; Amescua G; Yoo SH; Parel JM
Am J Ophthalmol; 2014 Jul; 158(1):64-70.e2. PubMed ID: 24792103
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial efficacy of corneal cross-linking in vitro and in vivo for Fusarium solani: a potential new treatment for fungal keratitis.
Zhu Z; Zhang H; Yue J; Liu S; Li Z; Wang L
BMC Ophthalmol; 2018 Mar; 18(1):65. PubMed ID: 29499665
[TBL] [Abstract][Full Text] [Related]
4. In vitro efficacy of antifungal treatment using riboflavin/UV-A (365 nm) combination and amphotericin B.
Sauer A; Letscher-Bru V; Speeg-Schatz C; Touboul D; Colin J; Candolfi E; Bourcier T
Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):3950-3. PubMed ID: 20335618
[TBL] [Abstract][Full Text] [Related]
5. Comparison of corneal collagen cross-linking (PACK-CXL) and voriconazole treatments in experimental fungal keratitis.
Özdemir HB; Kalkancı A; Bilgihan K; Göçün PU; Öğüt B; Karakurt F; Erdoğan M
Acta Ophthalmol; 2019 Feb; 97(1):e91-e96. PubMed ID: 29862655
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Antifungal Efficacy of 0.1% and 0.25% Riboflavin with UVA: A Comparative In Vitro Study.
Bilgihan K; Kalkanci A; Ozdemir HB; Yazar R; Karakurt F; Yuksel E; Otag F; Karabicak N; Arikan-Akdagli S
Curr Eye Res; 2016 Aug; 41(8):1050-1056. PubMed ID: 26644282
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility of photodynamic therapy (UVA/riboflavin) against Staphylococcus aureus.
Kashiwabuchi RT; Khan Y; Carvalho FR; Hirai F; Campos MS; McDonnell PJ
Arq Bras Oftalmol; 2012; 75(6):423-6. PubMed ID: 23715147
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial activity of simulated solar disinfection against bacterial, fungal, and protozoan pathogens and its enhancement by riboflavin.
Heaselgrave W; Kilvington S
Appl Environ Microbiol; 2010 Sep; 76(17):6010-2. PubMed ID: 20639371
[TBL] [Abstract][Full Text] [Related]
9. Keratocyte cytotoxicity of riboflavin/UVA-treatment in vitro.
Wollensak G; Spoerl E; Reber F; Seiler T
Eye (Lond); 2004 Jul; 18(7):718-22. PubMed ID: 14739922
[TBL] [Abstract][Full Text] [Related]
10. In vivo thermographic analysis of the corneal surface in keratoconic patients undergoing riboflavin-UV-A accelerated cross-linking.
Mencucci R; Mazzotta C; Corvi A; Terracciano L; Rechichi M; Matteoli S
Cornea; 2015 Mar; 34(3):323-7. PubMed ID: 25474235
[TBL] [Abstract][Full Text] [Related]
11. Collagen cross-linking using riboflavin and ultraviolet-a for corneal thinning disorders: an evidence-based analysis.
Pron G; Ieraci L; Kaulback K;
Ont Health Technol Assess Ser; 2011; 11(5):1-89. PubMed ID: 23074417
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic efficacy of ultraviolet combined with riboflavin for the rabbit bacterial keratitis].
Su GY; Zheng PP; Su YD; Cao K; Gao C; Zhang Y; Li B; Liang QF
Zhonghua Yan Ke Za Zhi; 2018 Dec; 54(12):902-910. PubMed ID: 30526789
[No Abstract] [Full Text] [Related]
13. The biology of corneal cross-linking derived from ultraviolet light and riboflavin.
Santhiago MR; Randleman JB
Exp Eye Res; 2021 Jan; 202():108355. PubMed ID: 33171194
[TBL] [Abstract][Full Text] [Related]
14. Antifungal efficacy of photodynamic therapy with TONS 504 for pathogenic filamentous fungi.
Sueoka K; Chikama T; Pertiwi YD; Ko JA; Kiuchi Y; Sakaguchi T; Obana A
Lasers Med Sci; 2019 Jun; 34(4):743-747. PubMed ID: 30284654
[TBL] [Abstract][Full Text] [Related]
15. Effect of the retention ring-assisted continuous application of riboflavin in pulsed-light accelerated corneal collagen cross-linking on the progression of keratoconus.
Kim CY; Kim MK
BMC Ophthalmol; 2019 Mar; 19(1):72. PubMed ID: 30866862
[TBL] [Abstract][Full Text] [Related]
16. Blue light (470 nm) effectively inhibits bacterial and fungal growth.
De Lucca AJ; Carter-Wientjes C; Williams KA; Bhatnagar D
Lett Appl Microbiol; 2012 Dec; 55(6):460-6. PubMed ID: 23009190
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the in vitro antimicrobial properties of ultraviolet A/riboflavin mediated crosslinking on Candida albicans and Fusarium solani.
Sun B; Li ZW; Yu HQ; Tao XC; Zhang Y; Mu GY
Int J Ophthalmol; 2014; 7(2):205-10. PubMed ID: 24790859
[TBL] [Abstract][Full Text] [Related]
18. Photochemical eradication of methicillin-resistant Staphylococcus aureus by blue light activation of riboflavin.
Makdoumi K; Goodrich R; Bäckman A
Acta Ophthalmol; 2017 Aug; 95(5):498-502. PubMed ID: 28205348
[TBL] [Abstract][Full Text] [Related]
19. Collagen fiber diameter in the rabbit cornea after collagen crosslinking by riboflavin/UVA.
Wollensak G; Wilsch M; Spoerl E; Seiler T
Cornea; 2004 Jul; 23(5):503-7. PubMed ID: 15220736
[TBL] [Abstract][Full Text] [Related]
20. First proposed efficacy study of high versus standard irradiance and fractionated riboflavin/ultraviolet a cross-linking with equivalent energy exposure.
Krueger RR; Herekar S; Spoerl E
Eye Contact Lens; 2014 Nov; 40(6):353-7. PubMed ID: 25365552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
